Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Sep 06, 2024

SELL
$118.38 - $210.04 $406,043 - $720,437
-3,430 Closed
0 $0
Q3 2022

Sep 06, 2024

BUY
$118.07 - $194.18 $404,980 - $666,037
3,430 New
3,430 $406 Million
Q2 2022

Sep 06, 2024

BUY
$117.13 - $176.59 $9,370 - $14,127
80 Added 2.39%
3,430 $490 Million
Q1 2022

Sep 06, 2024

BUY
$126.46 - $235.05 $423,641 - $787,417
3,350 New
3,350 $577 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $18.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.